These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 24510924)

  • 1. Under-utilization of controller medications and poor follow-up rates among hospitalized asthma patients.
    Lintzenich A; Teufel RJ; Basco WT
    Hosp Pediatr; 2011 Jul; 1(1):8-14. PubMed ID: 24510924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low rates of controller medication initiation and outpatient follow-up after emergency department visits for asthma.
    Andrews AL; Teufel RJ; Basco WT
    J Pediatr; 2012 Feb; 160(2):325-30. PubMed ID: 21885062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled Corticosteroid Claims and Outpatient Visits After Hospitalization for Asthma Among Commercially Insured Children.
    Andrews AL; Bundy DG; Simpson KN; Teufel RJ; Harvey J; Simpson AN
    Acad Pediatr; 2017 Mar; 17(2):212-217. PubMed ID: 28259341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
    Sadatsafavi M; Lynd LD; De Vera MA; Zafari Z; FitzGerald JM
    Respir Med; 2015 Mar; 109(3):320-8. PubMed ID: 25596136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process quality measures and asthma exacerbations in the medicaid population.
    Yong PL; Werner RM
    J Allergy Clin Immunol; 2009 Nov; 124(5):961-6. PubMed ID: 19748660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA; Riedel AA; Carranza Rosenzweig JR
    Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality improvement methods improve inhaled corticosteroid prescribing in the emergency department.
    Andrews AL; Russell WS; Titus MO; Braden J; Word C; Cochran C; Adams S; Roberts JR
    J Asthma; 2014 Sep; 51(7):737-42. PubMed ID: 24697737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain.
    Feehan M; Ranker L; Durante R; Cooper DK; Jones GJ; Young DC; Munger MA
    J Clin Pharm Ther; 2015 Oct; 40(5):590-593. PubMed ID: 26291693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician adherence to the national asthma prescribing guidelines: evidence from national outpatient survey data in the United States.
    Navaratnam P; Jayawant SS; Pedersen CA; Balkrishnan R
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):216-21. PubMed ID: 18426140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.
    van Aalderen WM; Grigg J; Guilbert TW; Roche N; Israel E; Martin RJ; Colice G; Postma DS; Hillyer EV; Burden A; Thomas V; von Ziegenweidt J; Price D
    J Allergy Clin Immunol Pract; 2015; 3(5):721-31.e16. PubMed ID: 26032474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
    Luskin A; Bukstein D; Kocevar VS; Yin DD
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of an Inhaled Corticosteroid During a Pediatric Emergency Visit for Asthma: A Randomized Clinical Trial.
    Sampayo EM; Mazer-Amirshahi M; Camp EA; Zorc JJ
    Ann Emerg Med; 2017 Sep; 70(3):331-337. PubMed ID: 28262319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controller medication use and sleep problems in pediatric asthma: a longitudinal case-crossover analysis.
    Garrison MM; Lozano P; Christakis DA
    Arch Pediatr Adolesc Med; 2011 Sep; 165(9):826-30. PubMed ID: 21893649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes.
    Schatz M; Zeiger RS; Vollmer WM; Mosen D; Mendoza G; Apter AJ; Stibolt TB; Leong A; Johnson MS; Cook EF
    Chest; 2006 Jul; 130(1):43-50. PubMed ID: 16840381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urban primary care physicians' perceptions about initiation of controller medications during a pediatric emergency department visit for asthma.
    Sampayo EM; Agnant J; Chew A; Zorc J; Fein J
    Pediatr Emerg Care; 2012 Jan; 28(1):8-11. PubMed ID: 22193691
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.